Request for Covid-19 Impact Assessment of this Report
The United States Cannabis-based Medicines market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Cannabis-based Medicines market, reaching US$ million by the year 2028. As for the Europe Cannabis-based Medicines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Cannabis-based Medicines players cover GW Pharmaceuticals plc, INSYS Therapeutics, Aequus Pharmaceuticals, and Axim Biotechnologies, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Cannabis-based Medicines market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
CBD (Cannabidiol) Based
THC (Tetrahydrocannabinol) Based
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Oral Solution
Tablets
Patches
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
GW Pharmaceuticals plc
INSYS Therapeutics
Aequus Pharmaceuticals
Axim Biotechnologies
Revive Therapeutics
MGC Pharmaceuticals
ECHO Pharmaceuticals
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cannabis-based Medicines Market Size 2017-2028
2.1.2 Cannabis-based Medicines Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Cannabis-based Medicines Segment by Type
2.2.1 CBD (Cannabidiol) Based
2.2.2 THC (Tetrahydrocannabinol) Based
2.2.3 Others
2.3 Cannabis-based Medicines Market Size by Type
2.3.1 Cannabis-based Medicines Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Cannabis-based Medicines Market Size Market Share by Type (2017-2022)
2.4 Cannabis-based Medicines Segment by Application
2.4.1 Oral Solution
2.4.2 Tablets
2.4.3 Patches
2.4.4 Others
2.5 Cannabis-based Medicines Market Size by Application
2.5.1 Cannabis-based Medicines Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Cannabis-based Medicines Market Size Market Share by Application (2017-2022)
3 Cannabis-based Medicines Market Size by Player
3.1 Cannabis-based Medicines Market Size Market Share by Players
3.1.1 Global Cannabis-based Medicines Revenue by Players (2020-2022)
3.1.2 Global Cannabis-based Medicines Revenue Market Share by Players (2020-2022)
3.2 Global Cannabis-based Medicines Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Cannabis-based Medicines by Regions
4.1 Cannabis-based Medicines Market Size by Regions (2017-2022)
4.2 Americas Cannabis-based Medicines Market Size Growth (2017-2022)
4.3 APAC Cannabis-based Medicines Market Size Growth (2017-2022)
4.4 Europe Cannabis-based Medicines Market Size Growth (2017-2022)
4.5 Middle East & Africa Cannabis-based Medicines Market Size Growth (2017-2022)
5 Americas
5.1 Americas Cannabis-based Medicines Market Size by Country (2017-2022)
5.2 Americas Cannabis-based Medicines Market Size by Type (2017-2022)
5.3 Americas Cannabis-based Medicines Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cannabis-based Medicines Market Size by Region (2017-2022)
6.2 APAC Cannabis-based Medicines Market Size by Type (2017-2022)
6.3 APAC Cannabis-based Medicines Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Cannabis-based Medicines by Country (2017-2022)
7.2 Europe Cannabis-based Medicines Market Size by Type (2017-2022)
7.3 Europe Cannabis-based Medicines Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cannabis-based Medicines by Region (2017-2022)
8.2 Middle East & Africa Cannabis-based Medicines Market Size by Type (2017-2022)
8.3 Middle East & Africa Cannabis-based Medicines Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Cannabis-based Medicines Market Forecast
10.1 Global Cannabis-based Medicines Forecast by Regions (2023-2028)
10.1.1 Global Cannabis-based Medicines Forecast by Regions (2023-2028)
10.1.2 Americas Cannabis-based Medicines Forecast
10.1.3 APAC Cannabis-based Medicines Forecast
10.1.4 Europe Cannabis-based Medicines Forecast
10.1.5 Middle East & Africa Cannabis-based Medicines Forecast
10.2 Americas Cannabis-based Medicines Forecast by Country (2023-2028)
10.2.1 United States Cannabis-based Medicines Market Forecast
10.2.2 Canada Cannabis-based Medicines Market Forecast
10.2.3 Mexico Cannabis-based Medicines Market Forecast
10.2.4 Brazil Cannabis-based Medicines Market Forecast
10.3 APAC Cannabis-based Medicines Forecast by Region (2023-2028)
10.3.1 China Cannabis-based Medicines Market Forecast
10.3.2 Japan Cannabis-based Medicines Market Forecast
10.3.3 Korea Cannabis-based Medicines Market Forecast
10.3.4 Southeast Asia Cannabis-based Medicines Market Forecast
10.3.5 India Cannabis-based Medicines Market Forecast
10.3.6 Australia Cannabis-based Medicines Market Forecast
10.4 Europe Cannabis-based Medicines Forecast by Country (2023-2028)
10.4.1 Germany Cannabis-based Medicines Market Forecast
10.4.2 France Cannabis-based Medicines Market Forecast
10.4.3 UK Cannabis-based Medicines Market Forecast
10.4.4 Italy Cannabis-based Medicines Market Forecast
10.4.5 Russia Cannabis-based Medicines Market Forecast
10.5 Middle East & Africa Cannabis-based Medicines Forecast by Region (2023-2028)
10.5.1 Egypt Cannabis-based Medicines Market Forecast
10.5.2 South Africa Cannabis-based Medicines Market Forecast
10.5.3 Israel Cannabis-based Medicines Market Forecast
10.5.4 Turkey Cannabis-based Medicines Market Forecast
10.5.5 GCC Countries Cannabis-based Medicines Market Forecast
10.6 Global Cannabis-based Medicines Forecast by Type (2023-2028)
10.7 Global Cannabis-based Medicines Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 GW Pharmaceuticals plc
11.1.1 GW Pharmaceuticals plc Company Information
11.1.2 GW Pharmaceuticals plc Cannabis-based Medicines Product Offered
11.1.3 GW Pharmaceuticals plc Cannabis-based Medicines Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 GW Pharmaceuticals plc Main Business Overview
11.1.5 GW Pharmaceuticals plc Latest Developments
11.2 INSYS Therapeutics
11.2.1 INSYS Therapeutics Company Information
11.2.2 INSYS Therapeutics Cannabis-based Medicines Product Offered
11.2.3 INSYS Therapeutics Cannabis-based Medicines Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 INSYS Therapeutics Main Business Overview
11.2.5 INSYS Therapeutics Latest Developments
11.3 Aequus Pharmaceuticals
11.3.1 Aequus Pharmaceuticals Company Information
11.3.2 Aequus Pharmaceuticals Cannabis-based Medicines Product Offered
11.3.3 Aequus Pharmaceuticals Cannabis-based Medicines Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Aequus Pharmaceuticals Main Business Overview
11.3.5 Aequus Pharmaceuticals Latest Developments
11.4 Axim Biotechnologies
11.4.1 Axim Biotechnologies Company Information
11.4.2 Axim Biotechnologies Cannabis-based Medicines Product Offered
11.4.3 Axim Biotechnologies Cannabis-based Medicines Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Axim Biotechnologies Main Business Overview
11.4.5 Axim Biotechnologies Latest Developments
11.5 Revive Therapeutics
11.5.1 Revive Therapeutics Company Information
11.5.2 Revive Therapeutics Cannabis-based Medicines Product Offered
11.5.3 Revive Therapeutics Cannabis-based Medicines Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Revive Therapeutics Main Business Overview
11.5.5 Revive Therapeutics Latest Developments
11.6 MGC Pharmaceuticals
11.6.1 MGC Pharmaceuticals Company Information
11.6.2 MGC Pharmaceuticals Cannabis-based Medicines Product Offered
11.6.3 MGC Pharmaceuticals Cannabis-based Medicines Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 MGC Pharmaceuticals Main Business Overview
11.6.5 MGC Pharmaceuticals Latest Developments
11.7 ECHO Pharmaceuticals
11.7.1 ECHO Pharmaceuticals Company Information
11.7.2 ECHO Pharmaceuticals Cannabis-based Medicines Product Offered
11.7.3 ECHO Pharmaceuticals Cannabis-based Medicines Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 ECHO Pharmaceuticals Main Business Overview
11.7.5 ECHO Pharmaceuticals Latest Developments
12 Research Findings and Conclusion
Table 1. Cannabis-based Medicines Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of CBD (Cannabidiol) Based
Table 3. Major Players of THC (Tetrahydrocannabinol) Based
Table 4. Major Players of Others
Table 5. Cannabis-based Medicines Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Cannabis-based Medicines Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Cannabis-based Medicines Market Size Market Share by Type (2017-2022)
Table 8. Cannabis-based Medicines Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Cannabis-based Medicines Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Cannabis-based Medicines Market Size Market Share by Application (2017-2022)
Table 11. Global Cannabis-based Medicines Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Cannabis-based Medicines Revenue Market Share by Player (2020-2022)
Table 13. Cannabis-based Medicines Key Players Head office and Products Offered
Table 14. Cannabis-based Medicines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Cannabis-based Medicines Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Cannabis-based Medicines Market Size Market Share by Regions (2017-2022)
Table 19. Americas Cannabis-based Medicines Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Cannabis-based Medicines Market Size Market Share by Country (2017-2022)
Table 21. Americas Cannabis-based Medicines Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Cannabis-based Medicines Market Size Market Share by Type (2017-2022)
Table 23. Americas Cannabis-based Medicines Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Cannabis-based Medicines Market Size Market Share by Application (2017-2022)
Table 25. APAC Cannabis-based Medicines Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Cannabis-based Medicines Market Size Market Share by Region (2017-2022)
Table 27. APAC Cannabis-based Medicines Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Cannabis-based Medicines Market Size Market Share by Type (2017-2022)
Table 29. APAC Cannabis-based Medicines Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Cannabis-based Medicines Market Size Market Share by Application (2017-2022)
Table 31. Europe Cannabis-based Medicines Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Cannabis-based Medicines Market Size Market Share by Country (2017-2022)
Table 33. Europe Cannabis-based Medicines Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Cannabis-based Medicines Market Size Market Share by Type (2017-2022)
Table 35. Europe Cannabis-based Medicines Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Cannabis-based Medicines Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Cannabis-based Medicines Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Cannabis-based Medicines Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Cannabis-based Medicines Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Cannabis-based Medicines Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Cannabis-based Medicines Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Cannabis-based Medicines Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Cannabis-based Medicines
Table 44. Key Market Challenges & Risks of Cannabis-based Medicines
Table 45. Key Industry Trends of Cannabis-based Medicines
Table 46. Global Cannabis-based Medicines Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Cannabis-based Medicines Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Cannabis-based Medicines Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Cannabis-based Medicines Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Cannabis-based Medicines Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Cannabis-based Medicines Market Size Market Share Forecast by Application (2023-2028)
Table 52. GW Pharmaceuticals plc Details, Company Type, Cannabis-based Medicines Area Served and Its Competitors
Table 53. GW Pharmaceuticals plc Cannabis-based Medicines Product Offered
Table 54. GW Pharmaceuticals plc Cannabis-based Medicines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. GW Pharmaceuticals plc Main Business
Table 56. GW Pharmaceuticals plc Latest Developments
Table 57. INSYS Therapeutics Details, Company Type, Cannabis-based Medicines Area Served and Its Competitors
Table 58. INSYS Therapeutics Cannabis-based Medicines Product Offered
Table 59. INSYS Therapeutics Main Business
Table 60. INSYS Therapeutics Cannabis-based Medicines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. INSYS Therapeutics Latest Developments
Table 62. Aequus Pharmaceuticals Details, Company Type, Cannabis-based Medicines Area Served and Its Competitors
Table 63. Aequus Pharmaceuticals Cannabis-based Medicines Product Offered
Table 64. Aequus Pharmaceuticals Main Business
Table 65. Aequus Pharmaceuticals Cannabis-based Medicines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Aequus Pharmaceuticals Latest Developments
Table 67. Axim Biotechnologies Details, Company Type, Cannabis-based Medicines Area Served and Its Competitors
Table 68. Axim Biotechnologies Cannabis-based Medicines Product Offered
Table 69. Axim Biotechnologies Main Business
Table 70. Axim Biotechnologies Cannabis-based Medicines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Axim Biotechnologies Latest Developments
Table 72. Revive Therapeutics Details, Company Type, Cannabis-based Medicines Area Served and Its Competitors
Table 73. Revive Therapeutics Cannabis-based Medicines Product Offered
Table 74. Revive Therapeutics Main Business
Table 75. Revive Therapeutics Cannabis-based Medicines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Revive Therapeutics Latest Developments
Table 77. MGC Pharmaceuticals Details, Company Type, Cannabis-based Medicines Area Served and Its Competitors
Table 78. MGC Pharmaceuticals Cannabis-based Medicines Product Offered
Table 79. MGC Pharmaceuticals Main Business
Table 80. MGC Pharmaceuticals Cannabis-based Medicines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. MGC Pharmaceuticals Latest Developments
Table 82. ECHO Pharmaceuticals Details, Company Type, Cannabis-based Medicines Area Served and Its Competitors
Table 83. ECHO Pharmaceuticals Cannabis-based Medicines Product Offered
Table 84. ECHO Pharmaceuticals Main Business
Table 85. ECHO Pharmaceuticals Cannabis-based Medicines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. ECHO Pharmaceuticals Latest Developments
List of Figures
Figure 1. Cannabis-based Medicines Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cannabis-based Medicines Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Cannabis-based Medicines Market Size Market Share by Type in 2021
Figure 7. Cannabis-based Medicines in Oral Solution
Figure 8. Global Cannabis-based Medicines Market: Oral Solution (2017-2022) & ($ Millions)
Figure 9. Cannabis-based Medicines in Tablets
Figure 10. Global Cannabis-based Medicines Market: Tablets (2017-2022) & ($ Millions)
Figure 11. Cannabis-based Medicines in Patches
Figure 12. Global Cannabis-based Medicines Market: Patches (2017-2022) & ($ Millions)
Figure 13. Cannabis-based Medicines in Others
Figure 14. Global Cannabis-based Medicines Market: Others (2017-2022) & ($ Millions)
Figure 15. Global Cannabis-based Medicines Market Size Market Share by Application in 2021
Figure 16. Global Cannabis-based Medicines Revenue Market Share by Player in 2021
Figure 17. Global Cannabis-based Medicines Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Cannabis-based Medicines Market Size 2017-2022 ($ Millions)
Figure 19. APAC Cannabis-based Medicines Market Size 2017-2022 ($ Millions)
Figure 20. Europe Cannabis-based Medicines Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Cannabis-based Medicines Market Size 2017-2022 ($ Millions)
Figure 22. Americas Cannabis-based Medicines Value Market Share by Country in 2021
Figure 23. Americas Cannabis-based Medicines Consumption Market Share by Type in 2021
Figure 24. Americas Cannabis-based Medicines Market Size Market Share by Application in 2021
Figure 25. United States Cannabis-based Medicines Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Cannabis-based Medicines Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Cannabis-based Medicines Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Cannabis-based Medicines Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Cannabis-based Medicines Market Size Market Share by Region in 2021
Figure 30. APAC Cannabis-based Medicines Market Size Market Share by Application in 2021
Figure 31. China Cannabis-based Medicines Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Cannabis-based Medicines Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Cannabis-based Medicines Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Cannabis-based Medicines Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Cannabis-based Medicines Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Cannabis-based Medicines Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Cannabis-based Medicines Market Size Market Share by Country in 2021
Figure 38. Europe Cannabis-based Medicines Market Size Market Share by Type in 2021
Figure 39. Europe Cannabis-based Medicines Market Size Market Share by Application in 2021
Figure 40. Germany Cannabis-based Medicines Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Cannabis-based Medicines Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Cannabis-based Medicines Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Cannabis-based Medicines Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Cannabis-based Medicines Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Cannabis-based Medicines Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Cannabis-based Medicines Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Cannabis-based Medicines Market Size Market Share by Application in 2021
Figure 48. Egypt Cannabis-based Medicines Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Cannabis-based Medicines Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Cannabis-based Medicines Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Cannabis-based Medicines Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Cannabis-based Medicines Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Cannabis-based Medicines Market Size 2023-2028 ($ Millions)
Figure 54. APAC Cannabis-based Medicines Market Size 2023-2028 ($ Millions)
Figure 55. Europe Cannabis-based Medicines Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Cannabis-based Medicines Market Size 2023-2028 ($ Millions)
Figure 57. United States Cannabis-based Medicines Market Size 2023-2028 ($ Millions)
Figure 58. Canada Cannabis-based Medicines Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Cannabis-based Medicines Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Cannabis-based Medicines Market Size 2023-2028 ($ Millions)
Figure 61. China Cannabis-based Medicines Market Size 2023-2028 ($ Millions)
Figure 62. Japan Cannabis-based Medicines Market Size 2023-2028 ($ Millions)
Figure 63. Korea Cannabis-based Medicines Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Cannabis-based Medicines Market Size 2023-2028 ($ Millions)
Figure 65. India Cannabis-based Medicines Market Size 2023-2028 ($ Millions)
Figure 66. Australia Cannabis-based Medicines Market Size 2023-2028 ($ Millions)
Figure 67. Germany Cannabis-based Medicines Market Size 2023-2028 ($ Millions)
Figure 68. France Cannabis-based Medicines Market Size 2023-2028 ($ Millions)
Figure 69. UK Cannabis-based Medicines Market Size 2023-2028 ($ Millions)
Figure 70. Italy Cannabis-based Medicines Market Size 2023-2028 ($ Millions)
Figure 71. Russia Cannabis-based Medicines Market Size 2023-2028 ($ Millions)
Figure 72. Spain Cannabis-based Medicines Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Cannabis-based Medicines Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Cannabis-based Medicines Market Size 2023-2028 ($ Millions)
Figure 75. Israel Cannabis-based Medicines Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Cannabis-based Medicines Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Cannabis-based Medicines Market Size 2023-2028 ($ Millions)
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...